Anti-Mesothelin CAR Lentivirus (P4 ScFv-CD8-4-1BB-CD3ζ)

Catalog #
78703
$1,150 *
Size: 50 µl
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Anti-mesothelin CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain fragment variable) of anti-mesothelin (Clone P4) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1).

A

B

Figure 1. (A) Schematic of the lenti-vector used to generate the anti-mesothelin CAR lentivirus and (B) Construct diagram showing components of the anti-mesothelin CAR.

Synonyms
CAK1 antigen, Pre-pro-megakaryocyte-potentiating factor, Megakaryocyte-potentiating factor (MPF), MSLN, MPF
Product Info
Storage and Usage
Citations
Supplied As
50 µl of anti-mesothelin CAR at a titer ≥ 3x108 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Materials Required But Not Supplied
Name Ordering Information
PBMC, Frozen BPS Bioscience #79059
Human Interleukin-2 BPS Bioscience #90184
EasySep™ Human CD4+ T Cell Isolation Kit Stemcell Technologies #17952
EasySep™ Human CD8+ T Cell Isolation Kit Stemcell Technologies #17953
Human CD3/CD28/CD2 T Cell Activator Stemcell Technologies #10970
Biotinylated Human Mesothelin BPS Bioscience #100291
PE-Streptavidin Biolegend #405203
Mesothelin - CHO Recombinant Cell Line BPS Bioscience #78132
IFN-g (Human) Colorimetric ELISA Detection Kit BPS Bioscience #79777
Formulation

The lentiviruses were produced from HEK293T cells, concentrated, and resuspended in DMEM.

UniProt #
Q13421
Background

Mesothelin (MSLN) is a glycophosphatidylinositol (GPI) linked cell-surface protein that is produced as a ~70 kDa precursor protein and cleaved by Furin protease to generate the ~40 kDa mature form. MSLN is frequently overexpressed in mesothelioma, ovarian, pancreatic, and non-small cell lung cancers, while its expression in normal tissues is restricted to the mesothelial lining. MSLN is a tumor-associated antigen and has been an attractive target for targeted immunotherapy, including drug-conjugated antibodies and chimeric antigen receptor T cells (CAR-T Cells).